Amla - The role of ayurvedic therapeutic herb in cancer

Asian Journal of Pharmaceutical and Clinical Research

Volumn 4, Issue 3, 2011, Pages 13-17

  Krishnaveni, M ^a   Mirunalini, S ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Anticarcinogenic; Antitumor activity; Chemoprevention; Medicinal herb; Phyllanthus emblica

Indexed keywords

ANTINEOPLASTIC AGENT; ELLAGIC ACID; EMBLICA OFFICINALIS EXTRACT; FEBRIFUGE; GALLIC ACID; GLYCOSIDE; HERBACEOUS AGENT; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; TANNIN DERIVATIVE; TRIPHALA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AYURVEDA; BARK; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG INDICATION; DRUG ISOLATION; DRUG MEGADOSE; DRUG RESEARCH; DRUG SAFETY; EMBLICA OFFICINALIS; FLOWER; FRUIT; GENOTOXICITY; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MUTAGENICITY; NONHUMAN; NUTRITIONAL VALUE; PHYTOCHEMISTRY; PLANT LEAF; PLANT SEED; PLANT STEM; REVIEW; SKIN CANCER; SKIN PAPILLOMA; TREATMENT RESPONSE;

EID: 79960099094     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer statistics. Cancer J Clin 2003; 53: 5-26.
2. World Health Organisation: Cancer, 2006.
3. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 1991; 5 Suppl: 5023-5044.
4. Atlanta GA. Cancer Facts and Figures. American Cancer Society 1995; 1-3.
5. Smith JJ, Tully P, Padberg RM. Chemoprevention: a primary cancer prevention strategy. Semin Oncol Nurs 2005; 21: 243-251.
6. Sporn MB, Liby KT. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat Clin Pract Oncol 2005; 2: 518-525.
7. Brenner DE, Gescher AJ. Cancer chemoprevention: lessons learned and future directions. Br J Cancer 2005; 93: 735-739.
8. Kim ES, Hong WK. The current state of cancer chemoprevention. J Natl Cancer Inst 2005; 97: 468-470.
9. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 1994; 54: 2015-2024.
10. Ito, N., Fukushima, S. and Tsuda, H., Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants. Crit Rev Toxicol 1985; 15: 109-150.
11. Hikino H. Traditional remedies and modern assessment: the case of ginseng. In: Wijesekera, ROB, editors. The Medicinal Plant Industry 2nd ed. Boca Raton, Florida, CRC Press, 1991. pp. 149-166.
12. Lamartimere CA, Murrill WB, Manzalillo PA, Zhangt JX, Barnes S, Zhang X, Wei H, Brown NM. Genistein alters the ontogeny of mammary gland development and protects against chemically induced mammary cancer in rats. Proc Soc Exp Biol Med 1998; 217: 358-364.
13. Surh YJ, Lee E, Lee JM. Chemopreventive properties of some pungent ingredients present in red pepper and ginger. Mutation Res 1998; 402: 259-267.
14. Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 2002;40: 1091-1097.
15. Atal CK, Kapoor BM. Cultivation and utilization of medicinal plants (Eds. PID CSIR), 1989.
16. Siddiqui HH. Safety of herbal drugs-an overview. Drugs News and Views 1993; 1: 7-10.
17. Gopalan C, Sastri BVR, Balasubramaniam SC. Nutritive value ofIndian foods. NIN, Hyderabad, India, 1991.
18. Zhang Y, Tanaka T, Iwamoto Y, Yang C, Kouno I. Phyllaemblic acid, a novel highly oxygenated norbisabolane from the roots of Phyllanthus emblica. Tetrahedron Lett 2000; 41: 1781-1784.
19. Peryanayagam J, Sharma S, Joseph A, Christina A. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol 2004; 95: 83-5.
20. Kim HJ, Yokozawa T, Kim HY, Tohda C, Rao TP, Juneja LR. Influence of Amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol 2005; 51: 413-418.
21. Jeena KJ, Kuttan G, George J, Kuttan R. Antimutagenic and anticarcinogenic activity of Emblica officinalis Gaertn. J Clin Biochem Nutr 1996; 22: 171-176.
22. Jose JK, Kuttan G, Kuttan R. Antitumour activity of Emblica officinalis. J Ethnopharmacol 2001; 75: 65-69.
23. Rajeshkumar NV, Radahakrishna Pillai M, Kuttan R. Induction of Apoptosis in Mouse and Human Carcinoma Cell Lines by Emblica officinalis Polyphenols and its Effect on Chemical Carcinogenesis. J Exp Clin Cancer Res 2003; 22: 201-212.
24. Juss SS, Triphala - the wonder drug. Indian Med Gaz 1997; 131: 194-196.
25. Available at http://www.toddcaldecott.com/amalaki.html.
26. Singh MP, Malla SB, Rajbhandari SB, Manandhar A. Medicinal plants of Nepal- retrospects and prospects. Economic Botany 1979; 33: 185-198.
27. His Majesty's Government of Nepal, Ministry of Forest and Soil Conservation, Department of Medicinal Plants. Medicinal Plants of Nepal (3rd ed). His Majesty's Government Press, Kathmandu, 1982, pp. 185.
28. Jayaweera DMA. Medicinal Plants (Indigenous and Exotic/ Used in Ceylon. Part II. Government Press, Kathmandu, 1982, pp. 185.
29. Bunyapraphatsara N. Personal communication: uses of Phyllanthus species in traditional Thai medicine, translated from nine books in Thai. Medicinal Plant Information Center,.Mahidol University, Bangkok.
30. Brun V, Schumacher T. Traditional Herbal Medicine in Northern Thailand. University of California Press, Berkeley, 1987, pp. 349.
31. Stuart GA. Chinese Materia Medica Vegetable Kingdom. American Presbyterian Mission Press, Shanghai, 1911, pp, 558.
32. st ed. Tibetan Medical publications India, 1994.
33. Dragendorff, G., Die Heilpflunzen der Verschiedenen Viilker und Zeiten. Verlag von Ferdinand Enke, Stuttgart, 1898; pp. 373-374.
34. Perry LM, Metzger J. Medicinal Plants of East and Southeast Asicu Attributed properties and Uses. MIT Press, Cambridge, MA, 1980, pp. 149-151.
35. Ghosal S, Tripathi VK, Chauhan S. Active constituent of Emblica officinalis: part 1st the chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem. 1996; 35: 941-948.
36. Habib-ur-Rehman KA, Yasin MA, Choudhary N, Khaliq, Atta-ur-Rahman MI, Choudary et al. Studies on the chemical constituents of Phyllanthus emblica. Nat Prod Res 2007;21: 775-81.
37. Khanna P, Bansal R. Phyllantidine and phyllantine from Emblica officinalis Gaertn leafs fruits and in vitro tissue cultures. Indian J Exp Biol 1975; 13: 82-83.
38. Zhang LZ, Zhao WH, Guo YJ, Tu GZ, Lin S, Xin LG. Studies on chemical constituents in fruits of Tibetan medicine Phyllanthusemblica. Zhongguo Zhong Yao Za Zhi 2003; 28: 940-3.
39. El-Desouky SK, Ryu SY, Kim YK. A new cytotoxic acylated apigenin glucoside from Phyllanthus emblica L. Nat Prod Res 2008; 22: 91-5.
40. Kapoor LD, Handbook of Ayurvedic Medicinal Plants. CRC, Press, Boca Raton, 1990.
41. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants. CDRI, Lucknow and Publications & Information Directorate, New Delhi, 1993.
42. Jain SK, Khurdiya DS. Aonla: Potential fruit for processing. Delhi Garden Maga 2000; 38: 50-51.
43. Barthakur NN, Arnold NP. Chemical analysis of the emblic (Phyllanthus emblica L.) and its potential as a food source. Scientia Horticult 1991, 47: 99-105.
44. Ngamkitidechakul C, Jaijoy K, Hansakul P, Soonthornchareonnon N, Sireeratawong S. Antitumour effects of phyllanthus emblica L., Induction of cancer cell apoptosis and Inhibition of in vivotumour promotion and in vitro invasion of human cancer cells. Phytotherapy Res 2010; 24: 1405-1413.
45. Khan MT, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri MS et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Intl J Oncol 2002; 21: 187-92.
46. Quaglia A, Bhattacharya S, Dhillon AP. Limitations of the histopathological diagnosis and prognostic assessment of hepatocellular carcinoma. Histopathology 2001;38:167-174.
47. Overall Evaluations of Carcinogenicity: An Updating of IARCMonographs., Lyon, France: IARC Scientific Publishers., 1987, 1-42.
48. IARC Hepatitis Viruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC Scientific Publishers, 1994, 59.
49. Young KJ, Lee PN. Intervention studies on cancer. Eur J Cancer Prev 1999; 8: 91-103.
50. Sarwat Sultana, Salahuddin Ahmed and Tamanna Jahangir., Emblica officinalis and hepatocarcinogenesis: A chemopreventive study in Wistar rats. J Ethnopharmacol 2008; 118: 1-6.
51. Skin cancer (what you need to know about). National Institutes of Health, National cancer Institute, NIH Publication no. 1993, 94-1563.
52. Facts on Skin Cancer. American Cancer Society Publication 99-200. Rev. 8/95, no. 2049.
53. Cancer Facts & Figure. American Cancer Society Publication 96-300, no. 5008-96, 1996, p. 17.
54. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States:incidence. J Am Acad Dermatol 1994; 30: 774-778.
55. Steward BW, Kleihues P. Reduction of exposure to ultraviolet radiation. World Cancer Report, Lyon, France. IARC Press, 2004, 141-143
56. Garima Sancheti, Archana Jindal, Rimpu Kumari, Goyal. Chemopreventive Action of Emblica Officinalis on Skin Carcinogenesis in mice. Asian Pacific J Cancer Prev 2005; 6: 197-201.
57. Madhavi D, Rudrama Devi K, Kesava Rao K, Reddy PP. Modulating effect of Phyllanthus fruit extract against lead genotoxicity in germ cells of mice. J Envi Biol 2007;28: 115-117.
58. Banu SM, Selvendiran K, Singh JP, Sakthisekaran D. Protective effect of Emblica officinalis ethanolic extract against 7,12- dimethylbenz(a) anthracene (DMBA) inducedgenotoxicity in Swiss albino mice. Hum Exp Toxicol.2004; 23: 527-31.
59. Nandi P, Talukder G, Sharma A. Dietary chemoprevention of clastogenic effects of 3,4-benzo(a)pyrene by Emblica officinalis Gaertn. fruit extract. Br J Cancer 1997; 76: 1279-1283.
60. Grover IS, Kaur S. Effect of Emblica officinalis Gaertn. (Indian gooseberry) fruit extract on sodium azide and 4-nitro-ophenylenediamine induced mutagenesis in Salmonella typhimurium. Indian J Exp Biol 1989; 27: 207-9.
61. Deep G, Dhiman M, Rao AR, Kale RK. Chemopreventive potential of Triphala (a composite Indian drug) on benzo(a)pyrene induced forestomach tumorigenesis in murine tumor model system. J Exp Clin Cancer Res 2005; 24: 555-563.
62. Kaur S, Michael H, Arora S, Harkonen PL, Kumar S. The in vitro cytotoxic and apoptotic activity of Triphala - an Indian herbal drug. J Ethnopharmacol 2005; 81: 327-336.
63. Kaur S, Arora S, Kaur K, Kumar S. The in vitro antimutagenic activity of Triphala - an Indian herbal drug. Food Chem Toxicol 2002; 40: 527-534.
64. Hari Kumar KB, Sabu MC, Lima PS, Kuttan RJ, Radiat R. Modulation of haematpoetic system and antioxidant enzymes by Emblica officinalis gaertn and its protective role against gammaradiation induced damages in mice. 2004; 45: 549-555.
65. Sharma N, Trikha P, Athar M, Raisuddin S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem Toxicol 2000; 23: 477-484.
66. Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six Rasayana herbs used in Ayurvedic medicine. Phytother Res 1999; 13: 275-291.
67. Biswas S, Talukder G, Sharma A. Protection against cytotoxic effects of arsenic by dietary supplementation with crude extract of Emblica officinalis fruit Phytother Res 1999;13:513-516.